“CKD is a national health emergency. It is not only the leading cause of hospitalisation, but also a major driver of cardiovascular events in Australia,” said Dirk Otto, the general manager of Boehringer Ingelheim Australia and New Zealand.
BI-Lilly Alliance mark kidney disease PBS listing for SGLT-2 inhibitor
April 2, 2024 Latest NewsBioPharma
Latest Video
New Stories
-
Australia 'is not an island' on pricing and we cannot be so arrogant to expect free product
August 13, 2026 - - Latest News -
Survey exposes deep gaps in neurological care across Australia
August 13, 2026 - - Latest News -
US childhood vaccine move away from combinations contrasts with Australia’s national schedule
August 12, 2026 - - Latest News -
Former minister joins DBG Health board as company broadens healthcare ambition
August 12, 2026 - - Latest News -
A sage appointment that puts DBG Health another step closer to a serious understanding of decision-making
August 12, 2026 - - Latest News -
Patients welcome the timely PBS listing of rare cancer therapy
August 12, 2026 - - Latest News -
How education exposes the moral and ethical limits of our health decision-making
August 11, 2026 - - Latest News

